ADMA Biologics Inc (ADMA)
20.29
+0.72
(+3.68%)
USD |
NASDAQ |
Oct 04, 16:00
20.26
-0.03
(-0.15%)
After-Hours: 20:00
ADMA Biologics Shareholders Equity (Annual): 135.21M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 135.21M |
| December 31, 2022 | 151.97M |
| December 31, 2021 | 141.17M |
| December 31, 2020 | 88.25M |
| December 31, 2019 | 26.19M |
| December 31, 2018 | 19.77M |
| December 31, 2017 | 40.33M |
| Date | Value |
|---|---|
| December 31, 2016 | -4.457M |
| December 31, 2015 | 0.821M |
| December 31, 2014 | 6.009M |
| December 31, 2013 | 21.57M |
| December 31, 2012 | 9.424M |
| June 30, 2011 | -0.0013M |
| June 30, 2010 | -0.0003M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
26.19M
Minimum
2019
151.97M
Maximum
2022
108.56M
Average
135.21M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Assembly Biosciences Inc | 41.10M |
| TG Therapeutics Inc | 160.50M |
| Varex Imaging Corp | 567.70M |
| Krystal Biotech Inc | 778.64M |
| Bioventus Inc | 173.59M |